P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trial
Ji Woong Roh(Severance Hospital), Young Bin Song(Samsung Medical Center), Kyeong Ho Yun(Wonkwang University Hospital), Hyeon‐Cheol Gwon(Samsung Medical Center), Hyuck‐Jun Yoon(Keimyung University), Young Youp Koh(Chosun University Hospital), Jang Hyun Cho, Jeong Hoon Yang(Samsung Medical Center), Seung Uk Lee(Inje University), Seok Kyu Oh(Wonkwang University), Woong Choi(Konkuk University Medical Center), Wang Soo Lee(Chung-Ang University Hospital), Deok‐Kyu Cho(Severance Hospital), Yong Hwan Park(Changwon National University), Woo Jin Jang(Ewha Womans University Medical Center), Byung Ryul Cho(Kangwon National University), Seung‐Woon Rha, Taek Kyu Park(Samsung Medical Center), Jin‐Ok Jeong(Chungnam National University Hospital), Ju Hyeon Oh(Chonnam National University Hospital), Eul‐Soon Im, Jang‐Whan Bae(Chungbuk National University), Joo‐Yong Hahn(Samsung Medical Center), Dong‐Bin Kim(St. Paul's Hospital), Sang Hoon Lee(Samsung Medical Center), Jong‐Young Lee(Samsung Medical Center), Jae Woong Choi(Eulji University), Seung‐Hyuck Choi(Samsung Medical Center), Woo Jung Chun(Samsung (South Korea)), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Jin‐Ho Choi(Ulsan College), Joo Myung Lee(Samsung Medical Center)
Cited by 23
Related Papers
Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease
|New England Journal of Medicine|2011|683
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease
|New England Journal of Medicine|2015|505
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493